Cyrus Harmon
Founder bei OLEMA PHARMACEUTICALS, INC.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Cyrus L.
Harmon is the founder.
He founded Neomorphics, Inc. in 1996, where he served as the Chief Executive Officer from 1996 to 2000.
He also founded Olema Pharmaceuticals, Inc. in 2006 and currently holds the title of Director.
In addition to his founding positions, Dr. Harmon previously worked at Affymetrix, Inc. as the General Manager from 2000 to 2002.
Dr. Harmon obtained his undergraduate and doctorate degrees from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2024 | 948 311 ( 1,70% ) | 11 Mio $ | 31.03.2024 |
Aktive Positionen von Cyrus Harmon
| Unternehmen | Position | Beginn |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Founder | 07.08.2006 |
Ehemalige bekannte Positionen von Cyrus Harmon
| Unternehmen | Position | Ende |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01.01.2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 01.01.2000 |
Ausbildung von Cyrus Harmon
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
